We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in Japan
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 56 days · 56 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 56 days • 1 price levels
Price Analysis
Most common price: £495 (56 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 56 days
Description
This study covers the latent demand outlook for anti-rejection drugs and immunosuppressants for liver diseases treatments across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for anti-rejection drugs and immunosuppressants for liver diseases treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anti-rejection drugs and immunosuppressants for liver diseases treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AstraZeneca, Bayer, Bristol-Myers Squibb, Gilead Sciences, Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Company, Novartis International, Pfizer, and Sanofi. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Product Specifications
- Format
- paperback
- ASIN
- B0BP9GVRLM
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 08 December 2022
Similar Products You Might Like
98% match
The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments
Price unavailable
97% match
The 2023-2028 Outlook for Liver Health Supplements in Japan
£495.00
03 Sep 2026
97% match
The 2025-2030 World Outlook for Liver Disease Treatments
Price unavailable
97% match
The 2023-2028 Outlook for Liver Cirrhosis Drugs in China
£495.00
24 Aug 2026
97% match
The 2023-2028 Outlook for Liver Health Supplements in China
£495.00
27 Aug 2026
97% match
The 2023-2028 Outlook for Liver Health Supplements in India
£515.00
03 Sep 2026
97% match
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
Price unavailable
97% match
The 2023-2028 Outlook for Liver Health Supplements in the United States
£520.00
03 Sep 2026
96% match
Chronic Liver Disease: From Molecular Biology to Therapy (Hepatology Research and Clinical Developments)
£252.99
27 Aug 2026
96% match
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
£595.00
27 Aug 2026
96% match
Autoimmune Liver Diseases: Autoimmune Hepatitis, PBC, and PSC, An Issue of Clinics in Liver Disease: Volume 28-1 (The Clinics: Internal Medicine, Volume 28-1)
Elsevier
£69.99
26 Sep 2026
96% match
The 2023-2028 Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests in Japan
£495.00
28 Aug 2026
96% match
Leberkrankheiten: Klinisch-morphologische Diagnostik und ihre Grundlagen
Springer
£77.49
19 Sep 2026
96% match
Liver Diseases: A Multidisciplinary Textbook
Springer
£88.24
27 Sep 2026
96% match
Management of Chronic Liver Diseases: Recent Advances
IntechOpen
£118.98
19 Sep 2026
96% match
Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis
IntechOpen
£119.00
23 Sep 2026
96% match
Liver Disease: Diagnosis, Treatment & Management (Hepatology Research and Clinical Developments)
£90.99
18 Sep 2026
96% match
The Liver in Systemic Disease, An Issue of Clinics in Liver Disease: Volume 29-3 (The Clinics: Internal Medicine, Volume 29-3)
Elsevier
£72.48
19 Sep 2026
96% match
Trends in Alcoholic Liver Disease Research - Clinical and Scientific Aspects
IntechOpen
£119.00
24 Sep 2026
96% match
Liver Cirrhosis: Debates and Current Challenges
IntechOpen
£119.00
19 Sep 2026
95% match
Liver Research and Clinical Management
IntechOpen
£119.00
19 Sep 2026
95% match
The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in Japan
£495.00
25 Aug 2026
95% match
Liver Diseases: Clinical Management
Foster Academics
£71.12
11 Sep 2026
95% match